View Article

Abstract

Urolithiasis is a condition that occurs when these stones exit the renal pelvis and move into the urinary collecting system, which includes the urethra, bladder, and urethra. It accounts for a large number of hospital visits and is frequently preventable by modification of risk factors and has a numerous treatment options. Many patients with urolithiasis can be managed with expectant management, analgesic, and anti-emetic medications; however, stones that are associated with obstruction, renal failure, and infection require further increasingly critical interventions. This review mainly focused on activity outlines the etiology, diagnosis, management, and treatment of urolithiasis and highlights the role of the interprofessional team in evaluating and treating patients with this condition.

Keywords

Urolithiasis, ureters, calculi, uric acid, struvite, cysteine

Reference

  1. Scales CD, Smith AC, Hanley JM, Saigal CS., Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. [PMC free article] [PubMed]
  2. Chung MJ. Urolithiasis and nephrolithiasis. JAAPA. 2017 Sep;30(9):49-50. [PubMed]
  3. Caudarella R, Vescini F. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Arch Ital Urol Androl. 2009 Sep;81(3):182-7. [PubMed]
  4. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997 Oct;8(10):1568-73. [PubMed]
  5. Espino-Grosso PM, Canales BK. Kidney Stones After Bariatric Surgery: Risk Assessment and Mitigation. Bariatr Surg Pract Patient Care. 2017 Mar 01;12(1):3-9. [PMC free article] [PubMed]
  6. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005 Jan 26;293(4):455-62. [PubMed]
  7. Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018 Nov;33(11):1033-1047. [PMC free article] [PubMed]
  8. Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF. Protease inhibitor-induced urolithiasis. Urology. 1997 Oct;50(4):508-11. [PubMed]
  9. Izzedine H, Lescure FX, Bonnet F. HIV medication-based urolithiasis. Clin Kidney J. 2014 Apr;7(2):121-6. [PMC free article] [PubMed]
  10. Parkhomenko E, De Fazio A, Tran T, Thai J, Blum K, Gupta M. A Multi-Institutional Study of Struvite Stones: Patterns of Infection and Colonization. J Endourol. 2017 May;31(5):533-537. [PubMed]
  11. Ma Q, Fang L, Su R, Ma L, Xie G, Cheng Y. Uric acid stones, clinical manifestations and therapeutic considerations. Postgrad Med J. 2018 Aug;94(1114):458-462. [PubMed]
  12. Eggermann T, Venghaus A, Zerres K. Cystinuria: an inborn cause of urolithiasis. Orphanet J Rare Dis. 2012 Apr 05;7:19. [PMC free article] [PubMed]
  13. Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, Traxer O, Tiselius HG. Kidney stones. Nat Rev Dis Primers. 2016 Feb 25;2:16008. [PMC free article] [PubMed]
  14. Foster G, Stocks C, Borofsky MS. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Agency for Healthcare Research and Quality (US); Rockville (MD): Jul, 2012. Emergency Department Visits and Hospital Admissions for Kidney Stone Disease, 2009. [PubMed]
  15. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct;290(10):1315-23. [PubMed]
  16. Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar;111(5):607-16. [PMC free article] [PubMed]
  17. Shadman A, Bastani B. Kidney Calculi: Pathophysiology and as a Systemic Disorder. Iran J Kidney Dis. 2017 May;11(3):180-191. [PubMed]
  18. Semins MJ, Matlaga BR. Kidney stones during pregnancy. Nat Rev Urol. 2014 Mar;11(3):163-8. [PubMed]
  19. Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016 Nov;13(11):654-662. [PMC free article] [PubMed]
  20. Moore CL, Daniels B, Gross CP, Luty S, Singh D. External Validation of the STONE Score. Ann Emerg Med. 2016 Feb;67(2):301-2. [PubMed]
  21. Gottlieb M, Long B, Koyfman A. The evaluation and management of urolithiasis in the ED: A review of the literature. Am J Emerg Med. 2018 Apr;36(4):699-706. [PubMed]
  22. Fontenelle LF, Sarti TD. Kidney Stones: Treatment and Prevention. Am Fam Physician. 2019 Apr 15;99(8):490-496. [PubMed]
  23. Türk C, Pet?ík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2016 Mar;69(3):468-74. [PubMed]
  24. Rajamahanty S, Grasso M. Flexible ureteroscopy update: indications, instrumentation and technical advances. Indian J Urol. 2008 Oct;24(4):532-7. [PMC free article] [PubMed]
  25. Desai M, Sun Y, Buchholz N, Fuller A, Matsuda T, Matlaga B, Miller N, Bolton D, Alomar M, Ganpule A. Treatment selection for urolithiasis: percutaneous nephrolithomy, ureteroscopy, shock wave lithotripsy, and active monitoring. World J Urol. 2017 Sep;35(9):1395-1399. [PubMed]
  26. Zisman AL. Effectiveness of Treatment Modalities on Kidney Stone Recurrence. Clin J Am Soc Nephrol. 2017 Oct 06;12(10):1699-1708. [PMC free article] [PubMed]
  27. Gul Z, Monga M. Medical and dietary therapy for kidney stone prevention. Korean J Urol. 2014 Dec;55(12):775-9. [PMC free article] [PubMed]

Photo
Pittu Vishnu Priya
Corresponding author

Department of Pharmaceutical Biotechnololgy, Joginpally B.R Pharmacy College, Yenkapally (V), Moinabad (M), Telangana, Hyderabad- 500 075.

Photo
Palle Sai Sharanya
Co-author

Department of Pharmaceutical Biotechnololgy, Joginpally B.R Pharmacy College, Yenkapally (V), Moinabad (M), Telangana, Hyderabad- 500 075.

Photo
Nanubothula Kushala Yadav
Co-author

Department of Pharmaceutical Biotechnololgy, Joginpally B.R Pharmacy College, Yenkapally (V), Moinabad (M), Telangana, Hyderabad- 500 075.

Photo
Gangavarapu Hari Priya
Co-author

Department of Pharmaceutical Biotechnololgy, Joginpally B.R Pharmacy College, Yenkapally (V), Moinabad (M), Telangana, Hyderabad- 500 075.

Photo
Kurva Navaneetha
Co-author

Department of Pharmaceutical Biotechnololgy, Joginpally B.R Pharmacy College, Yenkapally (V), Moinabad (M), Telangana, Hyderabad- 500 075.

Palle Sai Sharanya, Nanubothula Kushala Yadav, Gangavarapu Hari Priya, Kurva Navaneetha, Pittu Vishnu Priya, Evaluation And Management Of Urolithiasis, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 9, 257-264. https://doi.org/10.5281/zenodo.8339887

More related articles
Formulation And Evaluation Of Nebivolol Transderma...
K. Mugilan, A. Vasanthan, Senthilkumar K. L., Karthick S., ...
Literature-Based Review of the Drugs used for the ...
Tushar P Patil, Mayur B Mane , Rishikesh S Bachhav, Smita S Aher,...
Formulation And Evalution Of Nanoparticles Loaded ...
Vasanth B., A. Vasanthan`, Senthilkumar K. L, ...
Formulation And Evaluation Of Herbal Gel...
Rituraj Rajjan Singh, Somprabha Madhukar, Shruti Rathore, ...
Prenatal Fear Of Child Birth...
Sneha Bhoir, Saurabh Borde, Saloni Bhoir, Sidra Choudhary, ...
Related Articles
Formation And Characterization Of Silver Nanostructures From Limonia acidissima ...
Jatin Agarwal , Dr. Ashok Kumar Rajput, Akshanshu Patel, Sudhanshu Sagar, Shubham Rana, ...
Method Development and Validation of Indacaterol Maleate By RP HPLC In Bulk and ...
Manali Katkade, Anagha Baviskar, Kiran Kotade, Charushila Bhangale, ...
Evaluation Of The General Marketed Tablet ...
Bharat Jadhav, Rutuja Dhas, Sahil T. Shaikh, ...
Ozone And Ozonated Oils In Skin Diseases...
Salunke R. Yashraj, Saurabh R. Kharat , Sham Ganesh Ardad , Nimbalkar Vaibhav , Jadhav Anil B. , ...
Formulation And Evaluation Of Nebivolol Transdermal Drug Delivery System ...
K. Mugilan, A. Vasanthan, Senthilkumar K. L., Karthick S., ...
More related articles
Formulation And Evaluation Of Nebivolol Transdermal Drug Delivery System ...
K. Mugilan, A. Vasanthan, Senthilkumar K. L., Karthick S., ...
Literature-Based Review of the Drugs used for the treatment of COVID-19...
Tushar P Patil, Mayur B Mane , Rishikesh S Bachhav, Smita S Aher, ...
Formulation And Evaluation Of Nebivolol Transdermal Drug Delivery System ...
K. Mugilan, A. Vasanthan, Senthilkumar K. L., Karthick S., ...
Literature-Based Review of the Drugs used for the treatment of COVID-19...
Tushar P Patil, Mayur B Mane , Rishikesh S Bachhav, Smita S Aher, ...